Skip to main content
Physician-administered

How to get this medication

Ogivri is a specialty medication, which means it's costly and requires more steps than usual in order to get it. We break down the process for you.

Learn more about Ogivri

About Ogivri

prescription bottle
Ogivri (trastuzumab-dkst) is used to treat stomach and breast cancer. Ogivri is a HER2 Receptor Antagonist, which works by targeting cancer cells that express HER2. The most common form of Ogivri is a 150mg vial. It is also available as a 420mg vial. Ogivri is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. It may be covered by some Medicare and insurance plans.

Other HER2 Receptor Antagonists

Related conditions

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.